Beaumont Financial Advisors’s Franklin Genomic Advancements ETF HELX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-139,425	Closed	-$7.3M	–	364
2021 Q3	$7.3M	Buy	+139,425	New	+$7.3M	0.56%	51